Fredric Zaino is the founder, Managing Partner, and Chief Investment Officer of Keystone Capital Partners. See contact routes.
Fredric Zaino is the founder, Managing Partner, and Chief Investment Officer of Keystone Capital Partners, a New York-based firm he established in 2019 after spending over 15 years at Millennium Management where he focused on Biotech and MedTech investments. His investment thesis targets overlooked micro-cap, small-cap, and mid-cap public and private companies, with primary sector focus on biotechnology, medical technology, real estate, and consumer products. Keystone plans to invest roughly $50 million total and currently does not seek outside capital, aiming to finance biotechs needing capital for new trials through private placement transactions. Notable portfolio companies include biotechnology firms PolarityTE (NASDAQ: PTE) and Vaccinex (NASDAQ: VCNX), which Keystone has already invested in. Zaino distinguishes his approach by emphasizing bottom-up fundamental analysis and unique investment structures to help underfunded companies reach their goals rather than pursuing traditional fund-raising models. He has publicly stated that the biotech sector will likely remain more robust than retail, restaurants, and travel sectors, reflecting his distinctive
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in New York.
Investors like Fredric Zaino · Full investor directory · Investor access · Company funding database